Sigma-1 Receptor Chaperones and Diseases

By  

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 9, Iss. 3, 2009-09 ,pp. : 184-189

Bentham Science Publishers

Access to resources Recommend Favorite

Sigma-1 Receptor Agonists as Therapeutic Drugs for Cognitive Impairment in Neuropsychiatric Diseases

By  

Current Pharmaceutical Design, Vol. 18, Iss. 7, 2012-03 ,pp. : 875-883

Bentham Science Publishers

Access to resources Recommend Favorite

The Role of Viruses in Neurodegenerative and Neurobehavioral Diseases

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 13, Iss. 7, 2014-09 ,pp. : 1213-1223

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting ligand-operated chaperone sigma-1 receptors in the treatment of neuropsychiatric disorders

By Hayashi Teruo   Tsai Shang-Yi   Mori Tomohisa   Fujimoto Michiko   Su Tsung-Ping  

Expert Opinion on Therapeutic Targets, Vol. 15, Iss. 5, 2011-05 ,pp. : 557-577

Informa Healthcare

Access to resources Recommend Favorite

P-gp Transporter and its Role in Neurodegenerative Diseases

By  

Current Topics in Medicinal Chemistry, Vol. 9, Iss. 2, 2009-02 ,pp. : 209-217

Bentham Science Publishers

Access to resources Recommend Favorite